Open access
Sep 2026
Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry.
BACKGROUND Finerenone, a non-steroidal mineralocorticoid receptor antagonist, improves cardiorenal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease. However, real-world data on its use in patients with concomitant heart failure remain limited. This study aimed to evaluate the baseline chara...
Serap Yadigar, Suat Akgür, T. Güvenç et al.
· Cardiovascular Drugs and The... · 0 citations